| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | +0.0% |
| Cost of Revenue | $2.5M | +7.5% |
| Gross Profit | $5.8M | -2.9% |
| R&D Expense | $3.2M | +24.8% |
| SG&A Expense | $4.4M | +9.9% |
| Operating Income | -$4.7M | -107.6% |
| Net Income | -$4.4M | -93.6% |
| EPS (Basic) | -$0.62 | -37.8% |
| EPS (Diluted) | -$0.62 | -37.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -81.2% |
| Accounts Receivable | $647K | +108.1% |
| Inventory | $1.6M | +128.6% |
| Current Assets | $24.1M | -0.3% |
| Total Assets | $24.7M | -0.9% |
| Current Liabilities | $1.1M | -19.0% |
| Total Liabilities | $1.3M | -21.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | -155.1% |
| Capital Expenditures | $23K | -82.4% |
| Investing Cash Flow | -$16.9M | — |
| Financing Cash Flow | $3.9M | -80.2% |
| Free Cash Flow | -$5.3M | -140.9% |
| Stockholders' Equity |
| $23.4M |
| +0.6% |